Trial Concerning the Frequency of Parastomal Hernia With or Without a Mesh (STOMAMESH)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Parastomal hernia is a relatively common and troublesome complication in patients with a stoma. The exact incidence is not known and depending on definitions and if a bulging is a hernia or not, as well as when after the operation the examination is performed, the incidence varies between 0-48%. A parastomal hernia may give the patient difficulties with appliance and leakage. From an economical point of view a stoma that requires special kinds of appliances is expensive. Theoretically, strengthening of the abdominal wall with a mesh at the the primary operation would reduce the risk for parastomal hernia. Recently presented data suggest that a mesh at the primary operation really does reduce the risk to develop a parastomal hernia. No negative side effects with the use of a mesh have been reported in these studies. All earlier studies have involved relatively small numbers of patients and short times of observation, and therefore under-dimensioned concerning potential negative late side-effects. Complications seen in other studies where mesh has been used in surgery of the bowel include fistulas and infections among others. To understand if mesh at the primary operation, in a safe way, reduces the risk for developing parastomal hernia compared to conventional surgery, is important to perform this new prospective randomised multicenter trial.
Specific aim:
To compare patients with colostomies with or without mesh at the primary operation. Primary endpoint is the incidence of parastomal hernia requiring surgery.
All patients at participating centers scheduled for permanent colostomy, after signing informed consent and meeting inclusion criteria, will be randomised to formation of a stoma with or without mesh.
If the inclusion criteria is fulfilled and informed consent is signed, the patient is randomised preoperatively.
| Condition | Intervention | Phase |
|---|---|---|
|
Parastomal Hernia |
Device: Polypropylene Mesh, density 25-40g/square meter |
Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention |
| Official Title: | STOMAMESH Prospective Randomised Multicenter Trial Concerning the Frequency of Parastomal Hernia With or Without a Mesh |
- The number of parastomal hernias in the two groups at 12 and 36 months postoperatively [ Time Frame: At 12 and 36 months postoperatively ] [ Designated as safety issue: No ]
- Quality of life related to health [ Time Frame: At 12 and 36 months postoperatively ] [ Designated as safety issue: Yes ]
- The health care systems total cost related to the stoma [ Time Frame: At 12 and 36 months postoperatively ] [ Designated as safety issue: Yes ]
- Rate of infections 30 days postoperatively [ Time Frame: At 30 days postoperatively ] [ Designated as safety issue: Yes ]
- Late complication related to the mesh leading to surgery [ Time Frame: At 12 and 36 months postoperatively ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 300 |
| Study Start Date: | January 2008 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Colostomy with a prophylactic mesh |
Device: Polypropylene Mesh, density 25-40g/square meter
colostomy with a prophylactic hernia mesh
|
| No Intervention: Colostomy without a prophylactic mesh |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient is scheduled for permanent colostomy elective or acute operation. The optimal site for stoma is marked preoperatively.
- No previous stoma.
- Over the age of 18.
- Informed consent signed by the patient.
Exclusion Criteria:
- Expected lifetime less then 3 years.
- Fecal peritonitis (perforated bowel with free intestinal content in the peritoneal cavity).
- Previous stoma.
Contacts and Locations| Contact: Pia Nasvall, MD | +46920282000 | pia.nasvall@nll.se |
| Contact: Michael Dahlberg, MD PhD | +46920282000 | michael.dahlberg@nll.se |
| Sweden | |
| Sunderby Hospital | Recruiting |
| Lulea, Sweden, 97180 | |
| Contact: Pia Nasvall, MD +46920282000 pia.nasvall@nll.se | |
| Study Chair: | Michael Dahlberg, MD PhD | Dept of Surgery Sunderby Hospital, Luela, Sweden |
More Information
No publications provided
| Responsible Party: | Pia Nasvall MD, Norrbottens lans landsting and Umea University |
| ClinicalTrials.gov Identifier: | NCT00917995 History of Changes |
| Other Study ID Numbers: | 07-081M |
| Study First Received: | June 8, 2009 |
| Last Updated: | June 10, 2009 |
| Health Authority: | Sweden: Regional Ethical Review Board Sweden: Swedish National Council on Medical Ethics |
Keywords provided by Norrbottens Lans Landsting:
|
parastomal hernia prophylactic mesh colostomy hernia |
Additional relevant MeSH terms:
|
Hernia Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 22, 2013